transferrin has been researched along with Metabolic Syndrome in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 16 (61.54) | 24.3611 |
| 2020's | 4 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fukada, H; Fukuhara, K; Ikejima, K; Kon, K; Morinaga, M; Nakadera, E; Uchiyama, A; Yaginuma, R; Yamashina, S | 1 |
| Al-Kzayer, LFY; Baz, HN; El Haddad, HE; El-Mougy, F; Hanna, HWZ | 1 |
| Bassols, J; Carreras-Badosa, G; Fernández-Real, JM; López-Bermejo, A; McLachlan, S; Prats-Puig, A; Suárez-Ortegón, MF; Wild, SH | 1 |
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Dörr, M; Felix, SB; Ittermann, T; Lerch, MM; Markus, MRP; Nauck, M; Pitchika, A; Schipf, S; Völzke, H | 1 |
| Acton, RT; Barton, JC | 2 |
| Chang, CC; Chang, JS; Chao, KC; Cheng, T; Fang, SU; Kao, WY; Lin, P; Lin, PY; Liu, JS; Tang, JH; Teng, KT; Yeh, HJ; Yuan, KC | 1 |
| Bardou-Jacquet, E; Beaumont-Epinette, MP; Ben Ali, Z; Brissot, P; Jouanolle, AM; Loreal, O | 1 |
| García-Morillo, JS; Gomez-Morales, LB; González-Estrada, A | 1 |
| Kilani, N; Marques-Vidal, P; Vollenweider, P; Waeber, G | 2 |
| Du, S; Meng, R; Tao, SJ; Wu, H; Zhao, HQ | 1 |
| Brigant, F; Chaby, G; Dadban, A; Hautefeuille, V; Lok, C; Nguyen-Khac, E | 1 |
| Chen, YJ; He, BT; Jin, Y; Jing, J; Li, XH; Ma, J; Yang, WH; Zhu, YN | 1 |
| Chaudhari, AS; Kumar, GN; Raghuvanshi, R | 1 |
| Bonfadini, S; Bovo, G; Coletti, S; Facchetti, R; Mariani, R; Paolini, V; Piperno, A; Pozzi, M; Riva, A; Salvioni, A; Trombini, P | 1 |
| Herman, WA; Korczowska, I; Lacka, K; Seńko, A | 1 |
| Altés, A; Baiget, M; Barceló, MJ; Crespo, L; Félez, J; Freixenet, N; Moreno-Rosel, MS; Payà, M; Pérez-Lucena, MJ; Serrano, A | 1 |
| Biesterfeld, S; Galle, PR; Geiss, HC; Lotz, J; Pöttgen, S; Roeddiger, R; Rossmann, H; Schattenberg, J; Schuchmann, M; Weber, MM; Zimmermann, A; Zimmermann, T | 1 |
| Buffet, C; Sogni, P | 1 |
| Bentley, P; Crawford, D; Goot, K; Hazeldine, S; Olynyk, J | 1 |
| Bendavid, C; Deugnier, Y; Lainé, F; Massart, C; Morcet, J; Perrin, M | 1 |
| Bogdański, P; Chyrek, R; Jabłecka, A; Pupek-Musialik, D | 1 |
| Deugnier, Y; Gandon, Y; Jouanolle, AM; Juhel, C; Olivié, D; Turlin, B | 1 |
| André, P; Balkau, B; Caces, E; Ducimetière, P; Fumeron, F; Grandchamp, B; Kettaneh, A; Marre, M; Tichet, J; Vari, IS | 1 |
3 review(s) available for transferrin and Metabolic Syndrome
| Article | Year |
|---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
Topics: Alcohol Drinking; Benzoates; Biopsy; Cataract; Cation Transport Proteins; Decision Trees; Deferasirox; Diet; Gaucher Disease; Genetic Testing; Hemochromatosis; Hemochromatosis Protein; Hepcidins; Histocompatibility Antigens Class I; Humans; Inflammation; Iron; Iron Chelating Agents; Iron Metabolism Disorders; Iron Overload; Liver; Macrophage Activation Syndrome; Magnetic Resonance Imaging; Membrane Proteins; Metabolic Syndrome; Mutation; Phlebotomy; Receptors, Transferrin; Transferrin; Triazoles | 2014 |
[Clinical evaluation of a hyperferritinemia].
Topics: Age Factors; Ferritins; Genotype; Hemochromatosis; Humans; Insulin Resistance; Iron Metabolism Disorders; Liver; Magnetic Resonance Imaging; Metabolic Syndrome; Reference Values; Risk Factors; Sex Factors; Transferrin | 2013 |
23 other study(ies) available for transferrin and Metabolic Syndrome
| Article | Year |
|---|---|
Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.
Topics: Alcohol Drinking; Alcoholism; Biomarkers; gamma-Glutamyltransferase; Humans; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Transferrin | 2022 |
Assessment of plasma catecholamines in patients with dysmetabolic iron overload syndrome.
Topics: Catecholamines; Dopamine; Epinephrine; Humans; Iron; Iron Overload; Metabolic Syndrome; Norepinephrine; Transferrin | 2022 |
Iron status and cardiometabolic risk in children.
Topics: Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Cross-Sectional Studies; Ferritins; Glycated Hemoglobin; Humans; Insulin Resistance; Iron; Longitudinal Studies; Metabolic Syndrome; Transferrin | 2023 |
Associations of iron markers with type 2 diabetes mellitus and metabolic syndrome: Results from the prospective SHIP study.
Topics: Adult; Biomarkers; Diabetes Mellitus, Type 2; Female; Ferritins; Humans; Iron; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Transferrin | 2020 |
Insulin Resistance and Metabolic Syndrome: Clinical and Laboratory Associations in African Americans Without Diabetes in the Hemochromatosis and Iron Overload Screening Study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Black or African American; Blood Glucose; Body Mass Index; Case-Control Studies; Female; Ferritins; Hemochromatosis; Humans; Insulin Resistance; Iron Overload; Male; Metabolic Syndrome; Middle Aged; Transferrin | 2018 |
Red Blood Cell Aggregation-Associated Dietary Pattern Predicts Hyperlipidemia and Metabolic Syndrome.
Topics: Adult; Anthropometry; Asian People; Biomarkers; Body Mass Index; Cell Aggregation; Cholesterol; Diet; Erythrocytes; Female; Hematocrit; Hemoglobins; Hepcidins; Humans; Hyperlipidemias; Iron; Linear Models; Male; Metabolic Syndrome; Middle Aged; Surveys and Questionnaires; Taiwan; Transferrin; Triglycerides; Young Adult | 2018 |
Sporadic porphyria cutanea tarda: treatment with chloroquine decreases hyperglycemia and reduces development of metabolic syndrome.
Topics: Adolescent; Adult; Chloroquine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Iron Overload; Male; Metabolic Syndrome; Middle Aged; Phlebotomy; Porphyria Cutanea Tarda; Transferrin; Treatment Outcome | 2014 |
Markers of iron metabolism and metabolic syndrome in Swiss adults.
Topics: Adult; Biomarkers; Female; Ferritins; Humans; Iron; Male; Metabolic Syndrome; Middle Aged; Postmenopause; Premenopause; Switzerland; Transferrin | 2014 |
Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study.
Topics: Age Factors; Blood Glucose; Body Mass Index; Female; Ferritins; Genotype; Humans; Insulin Resistance; Leukocyte Count; Liver Function Tests; Male; Metabolic Syndrome; Middle Aged; Sex Factors; Transferrin; United States; White People | 2015 |
Distribution of serum transferrin, and its associations with metabolic disorders among Chinese: A nation-wide, health and nutrition survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; China; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Nutrition Surveys; Obesity; Overweight; Risk Factors; Severity of Illness Index; Transferrin; Up-Regulation; Waist Circumference; Young Adult | 2015 |
Iron metabolism and incidence of metabolic syndrome.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Female; Ferritins; Follow-Up Studies; Humans; Incidence; Iron; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Prospective Studies; Transferrin | 2015 |
Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy.
Topics: Ferritins; Humans; Iron Overload; Male; Metabolic Syndrome; Middle Aged; Phlebotomy; Pruritus; Transferrin | 2015 |
Hepcidin and iron metabolism associated with cardiometabolic risk factors in children: A case-control study.
Topics: Adolescent; Biomarkers; Case-Control Studies; Chi-Square Distribution; Child; China; Female; Hepcidins; Humans; Iron; Lipids; Logistic Models; Male; Metabolic Syndrome; Odds Ratio; Receptors, Transferrin; Risk Factors; Transferrin; Waist Circumference | 2016 |
Genetically engineered Escherichia coli Nissle 1917 synbiotic counters fructose-induced metabolic syndrome and iron deficiency.
Topics: Animals; Body Weight; Diet; Dyslipidemias; Escherichia coli; Fructose; Genetic Engineering; Hyperglycemia; Iron; Iron Deficiencies; Liver; Mannitol Dehydrogenases; Metabolic Syndrome; Oxidative Stress; PQQ Cofactor; Probiotics; Rats; Synbiotics; Transferrin | 2017 |
Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome.
Topics: Adult; Aged; Fatty Liver; Female; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Insulin Resistance; Iron; Iron Overload; Liver; Male; Membrane Proteins; Metabolic Syndrome; Middle Aged; Predictive Value of Tests; Risk Factors; ROC Curve; Severity of Illness Index; Transferrin | 2008 |
Assessment of selected serum inflammatory markers of acute phase response and their correlations with adrenal androgens and metabolic syndrome in a population of men over the age of 40.
Topics: Acute-Phase Proteins; Adult; Age Factors; Aged; Aged, 80 and over; Aging; alpha 1-Antichymotrypsin; Biomarkers; C-Reactive Protein; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Inflammation Mediators; Male; Metabolic Syndrome; Middle Aged; Poland; Risk Factors; Transferrin | 2009 |
Detection of hereditary hemochromatosis and biochemical iron overload in primary care: a multicenter case finding study in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Ferritins; Follow-Up Studies; Genetic Predisposition to Disease; Genetic Testing; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histocompatibility Antigens Class I; Humans; Iron Overload; Male; Membrane Proteins; Metabolic Syndrome; Middle Aged; Spain; Transferrin; Young Adult | 2010 |
Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome.
Topics: Adult; Aged; Antimicrobial Cationic Peptides; C-Peptide; Carbohydrate Metabolism; Cholesterol, LDL; Fatty Liver; Female; Ferritins; Glucose Tolerance Test; Hepcidins; Humans; Insulin; Iron; Lipid Metabolism; Male; Metabolic Syndrome; Metabolome; Middle Aged; Non-alcoholic Fatty Liver Disease; Transferrin | 2011 |
Elevated serum ferritin - what should GPs know?
Topics: Alcohol Drinking; Australia; Diagnosis, Differential; Ferritins; Hemochromatosis; Humans; Iron; Iron Overload; Liver Diseases; Metabolic Syndrome; Obesity; Phlebotomy; Red Cross; Referral and Consultation; Transferrin | 2012 |
Reassessment of the algorithm for prediction of liver fibrosis in patients with features of the metabolic syndrome.
Topics: Algorithms; Enzyme-Linked Immunosorbent Assay; Humans; Hyaluronic Acid; Liver Cirrhosis; Metabolic Syndrome; Radioimmunoassay; Transferrin | 2006 |
[Evaluation of selected acute phase proteins in patients with metabolic syndrome].
Topics: Acute-Phase Proteins; Adult; alpha 1-Antichymotrypsin; alpha-Macroglobulins; Atherosclerosis; C-Reactive Protein; Female; Haptoglobins; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Orosomucoid; Reference Values; Transferrin | 2006 |
[Diagnosis of iron overload].
Topics: Adult; Anemia, Macrocytic; Biopsy; Hemochromatosis; Homozygote; Humans; Iron Overload; Liver; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Imaging; Metabolic Syndrome; Mutation; Siderosis; Transferrin | 2006 |
Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
Topics: Adult; Aged; Biomarkers; Cross-Sectional Studies; Female; Ferritins; Follow-Up Studies; France; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Time Factors; Transferrin | 2007 |